内镜下内痔硬化剂治疗的研究进展
作者:
作者单位:

上海交通大学医学院附属新华医院消化内镜诊治部

作者简介:

通讯作者:

中图分类号:

基金项目:

上海交通大学“交大之星”计划医工交叉研究课题(YG2019QNB32);新华医院院级临床创新项目(19XHCR16D))


Advancement of Endoscopic Sclerotherapy for Internal Hemorrhoids
Author:
Affiliation:

Department of Digestive Endoscopic Diagnosis and Treatment, Xinhua Hospital, Shanghai Jiaotong University School of Medicine

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 文章评论
    摘要:

    内痔是常见的良性肛管疾病,其治疗方法有保守治疗、微创治疗和手术治疗等。内镜下硬化剂治疗作为微创治疗中的一种,目前正逐渐成为内痔治疗的主要方法。本文主要围绕内镜下内痔硬化剂治疗的方法、疗效和不足等问题,对目前的研究结果进行了总结。

    Abstract:

    Internal hemorrhoid is a common kind of benign anal canal disease, treatments of which include traditional treatment, instrumental treatment and surgical treatment, etc. Nowadays, endoscopic sclerotherapy for internal hemorrhoids is gradually becoming the main method. Studies have shown that endoscopic sclerotherapy for internal hemorrhoids has reliable efficacy, higher safety, easy to operate, which is widely used in different levels of medical institutions. The application of transparent cap, sclerosing foam and miniprobe sonography plays a further role in the process of diagnosis and treatment. However, problems such as needle choice, the curative reliability of Ⅲ - Ⅳ hemorrhoids and long time recurrence need to be resolved. The standardized treatment and clinic guideline should be established in near future.

    参考文献
    相似文献
    引证文献
引用本文

张飞宇,沈峰,徐雷鸣.内镜下内痔硬化剂治疗的研究进展[J].中华消化内镜杂志,2021,38(9):693-695.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2021-03-28
  • 最后修改日期:2021-08-17
  • 录用日期:2021-06-07
  • 在线发布日期: 2021-09-27
  • 出版日期:
您是第位访问者

通信地址:南京市鼓楼区紫竹林3号《中华消化内镜杂志》编辑部   邮编:210003

中华消化内镜杂志 ® 2024 版权所有
技术支持:北京勤云科技发展有限公司